Jean-Marie Schneider

USPTO Granted Patents = 10 (Patent Applications = 1)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

Bial-portela Ca & S.a.

patents

2 out of 3

Produits Chimiques Auxiliaires Et De Synthese

patents

4. 1 out of 1

Produits Chimiques Auxiliaries Et De Synthese

patent

5. 1 out of 1

Products Chimiques Auxiliaires Et De Synthese

where one patent can have more than one assignee

Years Active: 2009-2018

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10059696 - Process for preparing 1,3-dihydroimidazole-2-thione derivatives (2018-08-28),

2. 9598350 - Process for preparing cinacalcet and pharmaceutically acceptable salts thereof (2017-03-21),

3. 9487477 - Crystalline phase of (3S,3S') 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine (2016-11-08),

4. 9346751 - Process for preparing 1, 3-Dihydroimidazole-2-Thione Derivatives (2016-05-24),

5. 9340497 - Method for the preparation of (3S,3S') 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid) (2016-05-17),

6. 9290439 - Process for preparing cinacalcet and pharmaceutically acceptable salts thereof (2016-03-22),

7. 9278921 - Crystalline phase of (3S.3S') 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) with L-lysine (2016-03-08),

8. 9187418 - Method for the preparation of (3S, 3S') 4,4′-disulfanediylbis (3-aminobutane 1-sulfonic acid) (2015-11-17),

9. 8592601 - Precursor phase and use thereof for preparing the magnesium tetrahydrate salt of an omeprazole enantiomer (2013-11-26),

10. 7619116 - Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation (2009-11-17),

Title: The Innovative Contributions of Jean-Marie Schneider

Introduction

Jean-Marie Schneider is a notable inventor based in Magnanville, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work focuses on innovative processes that enhance the preparation of various chemical compounds.

Latest Patents

One of his latest patents is a process for preparing 1,3-dihydroimidazole-2-thione derivatives. This invention relates to a method for synthesizing (R)-5-(2-(benzylamino)ethyl)-1-(6,8-difluorochroman-3-yl)-1H-imidazole-2(3H)-thione, along with its pharmaceutically acceptable salts, particularly the hydrochloride salt. Additionally, he has developed a process for preparing cinacalcet and its pharmaceutically acceptable salts. This patent involves reacting 3-trifluoromethylbenzaldehyde with a phosphorus-comprising derivative, leading to the formation of cinacalcet and its phosphate salt.

Career Highlights

Throughout his career, Jean-Marie Schneider has worked with prominent companies in the pharmaceutical industry, including Quantum Genomics and Bial-Portela & Ca S.A. His expertise in chemical processes has made him a valuable asset in these organizations.

Collaborations

He has collaborated with notable colleagues such as Jonathan Madec and Fabrice Balavoine, contributing to various innovative projects in the pharmaceutical sector.

Conclusion

Jean-Marie Schneider's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His innovative processes continue to impact the development of important chemical compounds.

This text is generated by artificial intelligence and may not be accurate.